July 18, 2024
2:00-3:30 p.m. ET
Courts and Researchers are Increasingly Focused on Genomics in Mass Tort Cancer Cases
Courts and Researchers are Increasingly Focused on Genomics in Mass Tort Cancer Cases
Webinar Sponsored By:
Join us for this CLE webinar on Thursday, July 18, 2024 from 2:00-3:30 pm ET.
Speakers:
- Kirk T. Hartley, Principal at LSP Group and ToxicoGenomica
- Leonel van Zyl, PhD., ToxicoGenomica, CEO, ArrayXpress Inc.
- Michael Zapata III, Executive Chairman, ArrayXpress, Inc. and Protochips Inc.
Topics for discussion include:
- Recent genomics rulings and motions
- Examples of genetic data missing from medical records
- Litigating the consequences of missing genetic data
- Prevalence of genomic mesotheliomas estimated at 20%
- Leveraging the value of tumor sequencing data
- CADD scores and VAF percentages
- Key recent papers on genomics and asbestos cancers
- Obtaining genetic data from commercial sequencing businesses
- Flexible reporting of sequencing results
- Trio sequencing for birth defects and parental exposure cases
Registration comes with CLE credit in one state and will be available in California, Illinois, New Jersey, New York, Ohio, Pennsylvania, and Texas.
For more information, contact Allison Gill, agill@perrinconferences.com.
A recording of this webinar is not available, but you can purchase the materials. Once you complete your purchase, you will receive an email with the link to the materials. These materials do not include any CLE credit. This webinar is presented by ToxicoGenomica. All information provided is their opinion.
Registration comes with CLE credit in one state and will be available in California, Illinois, New Jersey, New York, Ohio, Pennsylvania, and Texas.
For more information, contact Allison Gill, agill@perrinconferences.com.